UiPath (NYSE:PATH) Trading 0.9% Higher

Shares of UiPath Inc. (NYSE:PATH) traded up 0.9% during trading on Wednesday . The stock traded as high as $12.09 and last traded at $12.04. 1,389,684 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 9,836,723 shares. The stock had previously closed at $11.93.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Evercore ISI decreased their price target on shares of UiPath from $27.00 to $13.00 and set an “in-line” rating for the company in a research report on Thursday, May 30th. William Blair cut shares of UiPath from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 30th. BMO Capital Markets decreased their price target on shares of UiPath from $28.00 to $14.00 and set a “market perform” rating for the company in a research report on Monday, June 3rd. Canaccord Genuity Group decreased their price target on shares of UiPath from $30.00 to $19.00 and set a “buy” rating for the company in a research report on Friday, May 31st. Finally, Macquarie cut shares of UiPath from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $29.00 to $12.00 in a research report on Monday, June 3rd. Sixteen equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, UiPath currently has a consensus rating of “Hold” and a consensus price target of $18.06.

UiPath Stock Performance

The company’s 50 day moving average is $16.30 and its 200 day moving average is $20.89.

UiPath (NYSE:PATH) last announced its quarterly earnings results on Wednesday, May 29th. The healthcare company reported ($0.03) EPS for the quarter, hitting the consensus estimate of ($0.03). UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The firm had revenue of $335.11 million for the quarter, compared to analyst estimates of $332.84 million. Analysts predict that UiPath Inc. will post -0.2 earnings per share for the current fiscal year.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of UiPath stock in a transaction on Monday, May 6th. The shares were sold at an average price of $19.79, for a total value of $791,600.00. Following the transaction, the chief financial officer now directly owns 946,848 shares in the company, valued at $18,738,121.92. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 22.37% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Intech Investment Management LLC increased its stake in shares of UiPath by 3.1% during the fourth quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock worth $356,000 after acquiring an additional 426 shares during the period. 180 Wealth Advisors LLC increased its stake in shares of UiPath by 0.3% during the fourth quarter. 180 Wealth Advisors LLC now owns 188,950 shares of the healthcare company’s stock worth $4,497,000 after acquiring an additional 492 shares during the period. Global Financial Private Client LLC increased its stake in shares of UiPath by 9.3% during the first quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock worth $144,000 after acquiring an additional 551 shares during the period. Bleakley Financial Group LLC increased its stake in shares of UiPath by 4.9% during the fourth quarter. Bleakley Financial Group LLC now owns 12,691 shares of the healthcare company’s stock worth $315,000 after acquiring an additional 598 shares during the period. Finally, Simplicity Solutions LLC increased its stake in shares of UiPath by 4.9% during the fourth quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company’s stock worth $315,000 after acquiring an additional 598 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.